Medtronic showcases its R&D capabilities at Hyderabad centre

Medical device major India Medtronic Private Limited recently conducted a site visit as part of the 5th Health Writers Workshop organised by Heal Foundation in Hyderabad to showcase its engineering research and development (R&D) centre in the city.

Medtronic, which has globally invested $2.2 billion in R&D in FY 2017 and owns more than 53,000 patents across its therapy areas, has a large footprint in engineering research and development in India.

The two R&D centres in Hyderabad and Bangalore, which collectively employ more than 350 engineers, support global teams with product design and development capabilities to serve international and emerging markets, including India.

Meaningful innovation can come in many forms like a new feature to make a product more useful or a unique way to apply an evolving technology to a real-world problem. As a global leader in medical technology, Medtronic aspires to drive progress in innovation and devise powerful solutions with proven clinical and economic value as the basis of our offerings and value proposition,” said Madan Krishnan, Vice President and Managing Director, Medtronic, Indian Sub-continent.

The Hyderabad centre, called Medtronic Engineering and Innovation Center (MEIC), is a 80,000 sq feet state-of-the-art facility providing engineering and development support in the areas of design, analysis, hardware, software development, and testing.

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video